Association

– Data from Randomized Control Trial Will Advance Evidence for Evaluation and Treatment of Heart Disease by Studying Actual Disease: Atherosclerosis – ANN ARBOR, Mich., Nov. 11, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) announced…

TUCSON, Ariz., Sept. 13, 2023 (GLOBE NEWSWIRE) -- As masking mandates are being reintroduced in schools and medical facilities, the Association of American Physicians and Surgeons (AAPS) issued a statement Tuesday urging against the…

Express News Service CHENNAI: Days after the Supreme Court stayed Gauhati High Court order that stalled the election process of the Wrestling Federation of India, the ad-hoc panel granted recognition to the Assam…

Women diagnosed and treated for breast cancer have increased biological aging compared to women who remain free of breast cancer, according to a new study by researchers at the National Institutes of Health and their collaborators. Among…

An international research team from Queen Mary University of London, UK and the Rovereto Civic Museum Foundation, Italy has made a groundbreaking discovery regarding reptiles and their ability to match visual and auditory information. Their…

Nodwin Gaming has announced the second season of BGMI Masters Series 2023. After the success of the first season, held last year, the tournament is back, once again in partnership with Star Sports. Only this time, the stakes raised…

Reading Time: 2 minutes  Bede Gaming has appointed Dan Whiteley as its new Chief Technology Officer. Whiteley brings 25 years of experience in complex technology solutions and digital products, having previously held senior…

ASSOCIATED PRESS RICHMOND, Va. — The Colonial Athletic Association has changed its name to the Coastal Athletic Association.The association of schools located in nine states along the Atlantic…

The communications industry’s open standards development organisation, Broadband Forum, has signed an agreement in principle with the Fiber Broadband Association to advance the communications industry forward with what it calls…

Further Phase 3 analysis shows benefits of lecanemab on both amyloid-beta and tau, two underlying pathological hallmarks of Alzheimer’s disease New data on subcutaneous formulation shows promising PK /PD data modeling on efficacy…